0001415889-25-005168.txt : 20250221 0001415889-25-005168.hdr.sgml : 20250221 20250221181707 ACCESSION NUMBER: 0001415889-25-005168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250219 FILED AS OF DATE: 20250221 DATE AS OF CHANGE: 20250221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kinard David S CENTRAL INDEX KEY: 0001752439 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 25653575 MAIL ADDRESS: STREET 1: 13543 WATER CREST DRIVE CITY: FISHERS STATE: IN ZIP: 46038 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 4 1 form4-02212025_110204.xml X0508 4 2025-02-19 0001739104 Elanco Animal Health Inc ELAN 0001752439 Kinard David S C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 false true false false SEE REMARKS 0 Common Stock 2025-02-19 4 A 0 40247 0 A 191903 D Common Stock 2025-02-19 4 F 0 17968 11.24 D 173935 D Includes 454 shares acquired on April 30, 2024, 524 shares acquired on July 31, 2024, 464 shares acquired on October 31, 2024, and 568 shares acquired on January 31, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan. Executive Vice President, Human Resources, Corporate Affairs and Administration /s/ Amy C. Seidel, as Attorney-in-Fact for David S. Kinard 2025-02-21 EX-24 2 ex24-02212025_110204.htm ex24-02212025_110204.htm

POWER OF ATTORNEY

 May 14, 2024


Know all by these present that the undersigned hereby constitutes and appoints Shiv O’Neill, Todd S. Young, Megan Y. Brady, Amy C. Seidel, and Amra Hoso with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:

(1)

execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Elanco Animal Health Incorporated (the “Company”) or as a stockholder of the Company or as a trustee of a stockholder of the Company, a Form ID and Forms 3, 4, and 5 and Schedules 13D or 13G, including amendments thereto, relating to the securities of the Company in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such a Form ID and Form 3, 4, or 5 or Schedule 13D or 13G, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of each such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by each such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as each such attorney-in-fact may approve in each such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that each such attorney-in-fact, or each such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with, or liabilities that may arise under, Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file a Form ID and Forms 3, 4, and 5 or Schedules 13D or 13G with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

This Power of Attorney shall not revoke any powers of attorney previously executed by the undersigned. This Power of Attorney shall not be revoked by any subsequent power of attorney that the undersigned may execute, unless such subsequent power of attorney specifically provides that it revokes this Power of Attorney by referring to the date of the undersigned’s execution of this Power of Attorney.

[The remainder of this page has been intentionally left blank]



IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the day and year first above written.



/s/ David S. Kinard